This week, I discovered reports of groundbreaking research recently reported that was conducted by a group of researchers from the University of Kansas Science Translational Medicine. The researchers tested high doses of vitamin C given to ovarian cancer patients and found that it kills cancer cells while healthy cells are not affected. The study involved 22 women, animals and cancer cell cultures.
In an interview with the BBC News, Dr. Jeanne Drisko, a co-author of the study stated, “Patients are looking for safe and low-cost choices in their management of cancer. Intravenous vitamin C has that potential based on our basic science research and early clinical data.”